PUBLIC CONTRACT · 2019
Eculizumab 300 mg sol inj fr 30 ml IV
- Contract value
- €451,331.70
- Signed on
- 8 January 2019
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5580431PUBLISHED SUBJECT
Fornecimento de Eculizumab 300 mg sol inj fr 30 ml IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Coimbra, Coimbra
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Alexion Pharma Spain SL - Sucursal Portugal · Tax ID 980553768
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €451,331.70
- Procedure base price
- €451,331.70
- Total effective price
- €134,607.70
- Publication date
- 23 May 2019
- Award date
- 22 November 2018
- Signing date
- 8 January 2019
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Preço ou custo
- CPV code
- 33698000-9 - Produtos para fins clínicos
- Legal basis
- Artigo 24.º, n.º 1, alínea e), subalínea iii) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 4046288
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.